α-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet

Diabetes

Volumn 55, Issue 8, 2006, Pages 2238-2244

  Yi, Xianwen ^a   Maeda, Nobuyo ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Apo, apolipoprotein; STZ, streptozotocin; TBARS, thiobarbituric acid reactive substance

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSE; STREPTOZOCIN; THIOCTIC ACID; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; GLUTATHIONE; LIPID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ANIMAL; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; CHEMISTRY; CHOLESTEROL INTAKE; DIET; ERYTHROCYTE; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; MOUSE MUTANT;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL, DIETARY; DIABETES MELLITUS, EXPERIMENTAL; DIET; DIETARY FATS; ERYTHROCYTES; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOCTIC ACID;

EID: 33749363594     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0251     Document Type: Article

References (47)

1. World Health Organization: Diabetes mellitus [article online], 2002. WHO Fact Sheet no. 138. Available at www.who.int/mediacentre/factsheets/fs138/en
2. Howard BV, Rodriguez BL, Bennett PH, Harris MI, Hamman R, Kuller LH, Pearson TA, Wylie-Rosett J: Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: epidemiology. Circulation 105:e132-e137, 2002
3. Maritim AC, Sanders RA, Watkins JB 3rd: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24-38, 2003
4. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
5. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
6. Parthasarathy S, Rankin SM: Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res 31:127-143, 1992
7. Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation 109:III27-III32, 2004
8. Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL: High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22:1245-1251, 1999
9. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC: Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25:1919-1927, 2002
10. Mayer-Davis EJ, Monaco JH, Marshall JA, Rushing J, Juhaeri: Vitamin C intake and cardiovascular disease risk factors in persons with non-insulin-dependent diabetes mellitus: from the Insulin Resistance Atherosclerosis Study and the San Luis Valley Diabetes Study. Prev Med 26:277-283, 1997
11. Reed LJ: From lipoic acid to multi-enzyme complexes. Protein Sci 7:220-224, 1998
12. Packer L, Kraemer K, Rimbach G: Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17:888-895, 2001
13. Ziegler D: Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol 3:173-189, 2004
14. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D: The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid: the SYDNEY trial. Diabetes Care 26:770-776, 2003
15. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM: Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031, 1998
16. Zhang SH, Reddick RL, Burkey B, Maeda N: Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 94:937-945, 1994
17. Lapenna D, Ciofani G, Pierdomenico SD, Giamberardino MA, Cuccurullo F: Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 31:331-335, 2001
18. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG: Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242-247, 1989
19. -/- mice. J Clin Invest 107:333-340, 2001
20. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE: Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114:659-668, 2004
21. Kanter M, Meral I, Yener Z, Ozbek H, Demir H: Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp Med 201:213-219, 2003
22. Cyrus T, Yao Y, Rokach J, Tang LX, Pratico D: Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 107:521-523, 2003
23. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA: Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 4:1189-1192, 1998
24. Crawford RS, Kirk EA, Rosenfeld ME, LeBoeuf RC, Chait A: Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 18:1506-1513, 1998
25. Paul A, Calleja L, Joven J, Vilella E, Ferre N, Camps J, Girona J, Osada J: Supplementation with vitamin E and/or zinc does not attenuate atherosclerosis in apolipoprotein E-deficient mice fed a high-fat, high-cholesterol diet. Int J Vitam Nutr Res 71:45-52, 2001
26. Shaish A, George J, Gilburd B, Keren P, Levkovitz H, Harats D: Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model. Arterioscler Thromb Vasc Biol 19:1470-1475, 1999
27. Zhang SH, Reddick RL, Avdievich E, Surles LK, Jones RG, Reynolds JB, Quarfordt SH, Maeda N: Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J Clin Invest 99:2858-2866, 1997
28. Ivanov VN: Effect of lipoic acid on tissue respiration in rabbits with experimental atherosclerosis. Cor Vasa 16:141-150, 1974
29. Shih JC: Atherosclerosis in Japanese quail and the effect of lipoic acid. Fed Proc 42:2494-2497, 1983
30. Angelucci L, Mascitelli-Coriandoli E: Anticholesterol activity of alpha-lipoic acid. Nature 181:911-912, 1958
31. Kritchevsky D, Moyer AW: Anti-cholesterol activity of alpha-lipoic acid. Nature 182:396, 1958
32. Chen C, Loo G: Inhibition of lecithin: cholesterol acyltransferase activity in human blood plasma by cigarette smoke extract and reactive aldehydes. J Biochem Toxicol 10:121-128, 1995
33. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA: Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 113:1277-1287, 2004
34. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792, 1991
35. Otero P, Bonet B, Herrera E, Rabano A: Development of atherosclerosis in the diabetic BALB/c mice: prevention with vitamin E administration. Atherosclerosis 182:259-265, 2005
36. Zuccollo A, Shi C, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, Zang M, Xu S, Jiang B, Oliver-Krasinski JM, Cayatte AJ, Corda S, Lavielle G, Verbeuren TJ, Cohen RA: The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus. Circulation 112:3001-3008, 2005
37. Vikramadithyan RK, Hu Y, Noh HL, Liang CP, Hallam K, Tall AR, Ramasamy R, Goldberg IJ: Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest 115:2434-2443, 2005
38. Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Lund DD: Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction. Exp Diabesity Res 5:123-135, 2004
39. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH: α-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22:280-287, 1999
40. Zhao X, Miller JR, Jiang Y, Marletta MA, Cronan JE: Assembly of the covalent linkage between lipoic acid and its cognate enzymes. Chem Biol 10:1293-1302, 2003
41. Morikawa T, Yasuno R, Wada H: Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett 498:16-21, 2001
42. Yi X, Maeda N: Endogenous production of lipoic acid is essential for mouse development. Mol Cell Biol 25:8387-8392, 2005
43. Slijepcevic M, Helmke K, Federlin K: Islet transplantation in experimental diabetes in the rat. III. Studies in allogeneic streptozotocin-treated rats. Horm Metab Res 7:456-461, 1975
44. Gandy SE, Buse MG, Sorenson JR, Crouch RK: Attenuation of streptozotocin diabetes with superoxide dismutase-like copper(II)(3,5-diisopropylsalicylate)2 in the rat. Diabetologia 24:437-440, 1983
45. Rodrigues B, Poucheret P, Battell M, McNeill J: Experimental Models of Diabetes. Boca Raton, Florida, CRC Press, 1999
46. George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F: Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 109:1153-1163, 2002[
47. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU: Antiobesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10:727-733, 2004